Synthesis and Structure–Activity Relationships of 4-Pyridones as Potential Antimalarials

Clive Yeates(21c Consultancy (United Kingdom)), María Luisa León(GlaxoSmithKline (United Kingdom)), José M. Bueno(GlaxoSmithKline (United Kingdom)), José M. Fiandor(GlaxoSmithKline (United Kingdom)), Jesús Chicharro(GlaxoSmithKline (United Kingdom)), Neil J. Cheesman(GlaxoSmithKline (United Kingdom)), James M. Woolven(GlaxoSmithKline (United Kingdom)), Domingo Gargallo‐Viola(GlaxoSmithKline (United Kingdom)), Alan T. Hudson(GlaxoSmithKline (United Kingdom)), Esther Fernández(GlaxoSmithKline (United Kingdom)), Mitch Fry(GlaxoSmithKline (United Kingdom)), Helen Trimming(GlaxoSmithKline (United Kingdom)), Edward C. Capon(GlaxoSmithKline (United Kingdom)), Mary Pudney(GlaxoSmithKline (United Kingdom)), Esperanza Herreros(GlaxoSmithKline (Spain)), Federico G. De las Heras(GlaxoSmithKline (Spain)), John F. Batchelor(Wellcome Trust)
Journal of Medicinal Chemistry
April 9, 2008
Cited by 139


Related Papers